P095: Consequences of an IL2RA locus duplication in a very early onset inflammatory bowel disease patientECCO '18 Vienna
2018
P096: Failure to control inflammation as a driving force of symptoms and phenotype in the NSG mouse model of ulcerative colitis.ECCO '18 Vienna
2018
P097: BJ-1108, a 6-Amino-2,4,5-trimethylpyridin-3-ol analogue, ameliorates DSS-induced colitis in miceECCO '18 Vienna
2018
P098: Aryl hydrocarbon receptor ameliorates intestinal barrier dysfunction in colitis by regulating the myosin light-chain kinase signalling pathwayECCO '18 Vienna
2018
P099: Postprandial intestinal motility and related physiology in active small-bowel Crohn’s diseaseECCO '18 Vienna
2018
P100: Guanosine prevents nuclear factor-κB nuclear translocation ameliorating experimental colitis in ratsECCO '18 Vienna
2018
P102: Increased abundance of gut microbial virulence genes and pro-inflammatory pathways during Crohn’s disease exacerbationsECCO '18 Vienna
2018
P104: Gene expression profiles in inflamed colonic biopsies from newly diagnosed Crohn’s disease and ulcerative colitis patients differ depending on the age at diagnosisECCO '18 Vienna
2018
P105: Human neutrophil elastase degrades the therapeutic monoclonal antibodies effective in IBDECCO '18 Vienna
2018
P106: Bifidobacterium longum subsp. longum microbiota-secreted bioactive peptide as a novel immunomodulatory compound in the human gastrointestinal tractECCO '18 Vienna
2018
P107: MicroRNA signatures can differentiate the inflamed colonic mucosa from non-inflamed mucosa in ulcerative colitis patientsECCO '18 Vienna
2018
P108: Differential expression in colitis-associated cancer compared with Crohn’s disease and ulcerative colitisECCO '18 Vienna
2018
P109: Rifaximin and Saccharomyces boulardii increase stress resilience in TNBS-induced colitisECCO '18 Vienna
2018